2026 08 03 Earnings Bwxt Q2 Fy2026
Revenue +18% to $902M, government margin guide raised 19%→20.5%, FY26 EBITDA $662–672M; CFO dates the legacy-priced backlog roll-off ('fully expect that to be done by the end of 2026'), and the CEO says large forgings and zirconium tube supply are NOT constrained for BWXT.
view source ↗Summary
BWXT's Q2 FY2026 call (2026-08-03) answers two questions the wiki had open. First, the margin lag is dated and mechanical, not demand-driven: CFO Mike Fitzgerald attributes the government-segment gap to "backlog associated with older pricing arrangements with the customer" and says he "fully expect[s] that to be done by the end of 2026", while raising the government margin guide from >19% to ~20.5% mid-year. Second, CEO Russ Jevnin states that large forgings and zirconium tube supply are currently available to BWXT — direct demand-side commentary on the heavy-forge/melt scarcity question, from the buyer's seat.
Headline: revenue ~$902M (+18% YoY), adjusted EBITDA +7%, adjusted EPS +5%; FY2026 adjusted EBITDA raised to $662–672M, FCF raised to $345–360M, non-GAAP EPS $4.70–4.80, total revenue ~$3.8B. Commercial revenue growth guided ~45% (raised from ~30%), of which the PCG acquisition is >50%.
Transcript
(Targeted attributed extracts — see partial_reason in frontmatter. Figures and quotes are as
reported by the source; ellipses in quotes are the source's.)
Prepared remarks and operational commentary
Russ Jevnin (President and CEO): government operations delivered "outstanding operational execution and productivity improvements".
Mike Fitzgerald (CFO): "very strong operational performance...hitting significant increases in our efficiencies and throughput" across plants.
Russ Jevnin (President and CEO), on commercial-nuclear investment: "These investments will moderate near-term margin expansion, but they are essential to establishing the industrial scale."
Russ Jevnin (President and CEO), on competitive position after the Cambridge capacity expansion: "we sit right at the top" versus Doosan and Ence; BWXT will operate "the world's largest nuclear clean room".
Russ Jevnin (President and CEO), on new-build order timing: a "credible opportunity to secure at least one new build nuclear equipment order before the year-end", naming GE Vernova and Westinghouse work on AP1000, BWRX-300, and SMR opportunities at Darlington.
Russ Jevnin (President and CEO), on TRISO: "It's still a highly uncertain market...We're not yet ready to make a full capital commitment on it."
Russ Jevnin (President and CEO), on labor: "more challenging to find qualified trades people than it is to find nuclear engineers right now...turnover rates...are really low. It's mid-single digit or below 4%."
Russ Jevnin (President and CEO), on forward supply risk: "I would worry about it as we surge into this demand environment over the next two or three years."
Disclosed risk language on the advanced-reactor push: "Growth in advanced fuels, enrichment and new manufacturing sites depends on successful ramp-up", plus "Customer adoption uncertainty."
Medical divestiture: sale of "just over 80%" of the medical/isotope businesses; BWXT retains a 20% stake (est. ~$130M revenue at modestly accretive margin).
Guidance (FY2026, as raised on this call)
- Total revenue ~$3.8B (high-teens growth)
- Adjusted EBITDA $662M–$672M (raised $10M at midpoint)
- Free cash flow $345M–$360M (raised $30M)
- Non-GAAP EPS $4.70–$4.80
- Government segment margin ~20.5% (raised from >19%)
- Commercial segment margin ~13% (lowered from ~14%)
- Commercial revenue growth ~45% (raised from ~30%; PCG >50% of the increase)
Q&A
Ron Epstein (Bank of America): "How is supply chain holding out for you...Getting the raw materials you need?"
Russ Jevnin (President and CEO): "Things have been going pretty well. Zirconium tubes, large forgings, whatever we need, we've been able to get those materials."
Scott Deuschle (Deutsche Bank): "Why...hasn't Westinghouse...received a firm U.S. AP1000 order?"
Russ Jevnin (President and CEO): utilities are "rightly waiting to see how those [government SPV] deals come out before they step into it."
Marc Bianchi (TD Cowen): on the Ford-class ordering cadence update — "when we could start to see this update affecting your financial results?"
Russ Jevnin (President and CEO): long-lead items ordered in 2028 for a 2030 hull order; the four-year interval eliminates the prior 5-year gap "so that we would constantly have two Ford ship sets moving through our plants...takes that swale out."
Matt Akers (BNP Paribas): "Could you touch on margins...how you're thinking of that longer term?"
Mike Fitzgerald (CFO): started the year at ~19%, now guiding 20.5%; "we've started to see some of the margin enhancements...in the reflected results." On the drag: "backlog associated with older pricing arrangements with the customer...fully expect that to be done by the end of 2026."
Ron Epstein (Bank of America): "Did you guys quantify what the organic change was in your EBITDA guide?"
Mike Fitzgerald (CFO): "It's mostly organic."
Market reaction (source's framing)
Q2 revenue missed the $905.4M consensus by $3.8M (~0.4%) while adjusted EPS beat by $0.02; the stock fell 3.23% after hours, which the source attributes to investor focus on "higher spending plans" and margin dilution from the capacity build-out.